Catheter Precision Inc (VTAK)
0.5936
-0.02
(-2.69%)
USD |
NYAM |
May 17, 16:00
0.5936
0.00 (0.00%)
After-Hours: 20:00
Catheter Precision Research and Development Expense (Annual): 0.475M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.475M |
| December 31, 2022 | 6.392M |
| December 31, 2021 | 12.25M |
| December 31, 2020 | 8.955M |
| Date | Value |
|---|---|
| December 31, 2019 | 4.53M |
| December 31, 2018 | 2.776M |
| December 31, 2017 | 4.518M |
| December 31, 2016 | 1.715M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
0.475M
Minimum
2023
12.25M
Maximum
2021
6.521M
Average
6.392M
Median
2022
Research and Development Expense (Annual) Benchmarks
| Perspective Therapeutics Inc | 21.31M |
| Retractable Technologies Inc | 0.5812M |
| InfuSystems Holdings Inc | -- |
| Xtant Medical Holdings Inc | 1.336M |
| Asensus Surgical Inc | 37.02M |